BioCentury | Jun 21, 2017
Distillery Techniques

Drug delivery

...a long-acting release (LAR) formulation of exenatide, for Type II diabetes. Bristol-Myers Squibb Co. has Exenatide once weekly suspension...
BioCentury | Jul 9, 2012
Strategy

Triple play in diabetes

The addition of Amylin Pharmaceuticals Inc. 's glucagon-like peptide 1 franchise will give partners Bristol-Myers Squibb Co. and AstraZeneca plc three modern mechanisms in their commercial diabetes portfolio and five in the pipeline - more than...
BioCentury | May 11, 2009
Clinical News

Exenatide once weekly suspension: Phase I/II started

...weekly in 65 patients and healthy volunteers. Healthy volunteers will receive a single injection of exenatide once weekly suspension...
...Amylin Pharmaceuticals Inc. (NASDAQ:AMLN), San Diego, Calif. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Product: Exenatide once weekly suspension...
Items per page:
1 - 3 of 3